Acidosis láctica asociada a metformina
Citas
Wu MP, Liao HC, Liaw SJ. Metformin associated high anion gap metabolic acidosis: a case report. J Emerg Crit Care Med. 2007;18(4):173-8.
Misbin RI. The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care. 2004;27(7):1791-3.
DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 1999;131(4):281-303.
Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf. 2010;33(9):727-40.
Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):775-87.
Dawson D, Conlon C. Case study: metformin-associated lactic acidosis: could orlistat be relevant? Diabetes Care. 2003;26(8):2471-2.
Gómez-Navarro L, de Arriba G, Sánchez-Heras M, Pérez del Valle KM, Hernández-Sevillano B, Basterrechea MA, et al. The nephrologist's role in metformininduced lactic acidosis. Nefrologia. 2011;31(5):587-90.
The clinical presentation and classification of lactic acidosis. En: Cohen RD, Woods HF. Clinical and bio-chemical aspects of lactic acidosis. Oxford: Blackwell Scientific; 1976. p. 1-200.
Fitzgerald E, Mathieu S, Ball A. Metformin associated lactic acidosis. BMJ. 2009;339:b3660.
Wen YK. Impact of acute kidney injury on metformin-associated lactic acidosis. Int Urol Nephrol. 2009;41(4):967-72.
Scheen AJ. Metformin and lactic acidosis. Acta Clin Belg. 2011;66(5):329-31.
Sulkin TV, Bosman D, Krentz AJ. Contraindications to metformin therapy in patients with NIDDM. Diabetes Care. 1997;20(6):925-8.
Shadnia S, Barzi F, Askari A, Hassanian-Moghaddam H, Zamani N, Ebrahimian K. Metformin toxicity: a report of 204 cases from Iran. Curr Drug Saf. 2013;8(4):278-81.
Galea M, Jelacin N, Bramham K, White I. Severe lactic acidosis and rhabdomyolysis following metformin and ramipril overdose. Br J Anaesth. 2007;98(2):213-5.
Salpeter SR, Greyber E, Pasternak GA, Salpeter Posthumous EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;(1):CD002967.
